Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. […]
DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management Read Post »
When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without
Want insights into the biggest revenue-changing events? ➤ Get Your Certificate Today By tracking patent expirations, patent litigation, generic and
Free Course in Generic and Branded Drug Lifecycle Management Read Post »
How Much Time Are You Wasting on Manual, Repetitive Tasks? Stop wasting time on repetitive reports: Contact us Are your
Stop paying your staff to make repetitive reports Read Post »
New DrugPatentWatch module connects excipients and drug patents In response to user requests, DrugPatentWatch has added a new database of
Connecting Excipients with Drug Patents – New DrugPatentWatch module Read Post »
Are you tired of having to navigate complicated contracts to access the information you need? Let DrugPatentWatch free you from
This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution
The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA Read Post »
DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited
This article was first published by Elinevan Overbeeke, Sissel Michelsen, Mondher Toumi, Hilde Stevens, Mark Trusheim, Isabelle Huys, and StevenSimoens
Get fresh news and insights, drug patent expirations & more…
